FDA Commissioner to Review Abortion Pill

Compartió un vínculo

2025-06-03 20:00:07

FDA Commissioner Marty Makary confirmed that he will review the safety of the abortion drug mifepristone after a study revealed troubling adverse health outcomes exceeding the risks reported on its label.

0 Commentarios 0 Acciones 54 Views